Skip directly to search Skip directly to A to Z list Skip directly to page options Skip directly to site content

Volume 5, Number 1—February 1999


Using Monoclonal Antibodies to Prevent Mucosal Transmission of Epidemic Infectious Diseases

Larry Zeitlin*, Richard A. Cone*†, and Kevin J. Whaley*†Comments to Author 
Author affiliations: *ReProtect, LLC, Baltimore, Maryland, USA; †The Johns Hopkins University, Baltimore, Maryland, USA

Main Article

Table 3

Preventive vaccines or cures for major sexually transmitted disease pathogens

Pathogen Vaccine Cure DRSa
Chlamydia trachomatis no yes
Haemophilus ducreyi no yes X
Hepatitis B yes no
Herpes simplex 1 and 2 no no X
HIV-1 and 2 no no X
Human papilloma virus (HPV) no yesb
Neisseria gonorrhoeae no yes X
Treponema pallidum no yes
Trichomonas vaginalis no yes X

aDrug-resistant strains reported.
bSurgical removal of HPV-infected tissue is performed.HPV-related cervical cancer identified early has a high cure rate; however, in the United States, for every three new cases, there is approximately one death (117).

Main Article